Yahoo Web Search

Search results

1. • 

     Moderna’s First Vaccine Was a Big Hit. Its Second Is a Let Down

     Bloomberg via Yahoo Finance· 7 hours ago

     (Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion...

2. • 

     If You'd Invested $1,000 in Moderna Stock 5 Years Ago, Here's How Much You'd Have Today

     Motley Fool via Yahoo Finance· 4 hours ago

     Five years ago, pharmaceutical company Moderna (NASDAQ: MRNA) was mostly unknown. It was developing...

3. • 

     Positive week for Moderna, Inc. (NASDAQ:MRNA) institutional investors who lost 6.8% over the past...

     Simply Wall St. via Yahoo Finance· 5 hours ago

     Key Insights Significantly high institutional ownership implies Moderna's stock price is sensitive...

4. • 

     Moderna’s Promise of mRNA Undercut by New RSV Vaccine

     Bloomberg· 2 hours ago

     Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly...

5. • Moderna, Inc. (NASDAQ:MRNA) Shares Sold by Russell Investments Group Ltd.

     ETF DAILY NEWS· 12 hours ago

     Russell Investments Group Ltd. cut its holdings in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 28.3% during the 4th quarter, according to its most recent Form 13F ...

6. • 

     Moderna’s mRNA Dreams Meet Reality With First Post-Covid Shot

     Bloomberg· 7 hours ago

     The biotech’s lackluster new RSV vaccine undercuts the promise of mRNA to revolutionize health care....

7. • 

     Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?

     Investor's Business Daily· 1 day ago

     Moderna stock broke out for the first time in over a year on May 2 after the biotech company notched...

8. • Merit Financial Group LLC Lowers Stock Holdings in Moderna, Inc. (NASDAQ:MRNA)

     ETF DAILY NEWS· 10 hours ago

     Merit Financial Group LLC lowered its position in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 19.1% in the 4th quarter, according to its most recent 13F filing with the SEC ...

9. • 

     Sisk selected for MITC fit-out in Oxfordshire

     World Construction Network via Yahoo Finance· 4 hours ago

     Construction and engineering company Sisk has been selected as the preferred bidder for the fit-out of Moderna’s new drug substance and manufacturing...

10. • 

      Moderna (MRNA) Surpasses Market Returns: Some Facts Worth Knowing

      Zacks via Yahoo Finance· 2 weeks ago

      Moderna (MRNA) closed the most recent trading day at $107.97, moving +1.69% from the previous...